Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble ST2 is a marker for acute cardiac allograft rejection.
Pascual-Figal DA, Garrido IP, Blanco R, Minguela A, Lax A, Ordoñez-Llanos J, Bayes-Genis A, Valdés M, Moore SA, Januzzi JL. Pascual-Figal DA, et al. Among authors: moore sa. Ann Thorac Surg. 2011 Dec;92(6):2118-24. doi: 10.1016/j.athoracsur.2011.07.048. Epub 2011 Oct 28. Ann Thorac Surg. 2011. PMID: 22035779
Found in translation soluble ST2 and heart disease.
Moore SA, Januzzi JL Jr. Moore SA, et al. J Am Coll Cardiol. 2010 Jan 19;55(3):251-3. doi: 10.1016/j.jacc.2009.08.049. J Am Coll Cardiol. 2010. PMID: 20117404 Free article. No abstract available.
Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study.
Gaggin HK, Mohammed AA, Bhardwaj A, Rehman SU, Gregory SA, Weiner RB, Baggish AL, Moore SA, Semigran MJ, Januzzi JL Jr. Gaggin HK, et al. Among authors: moore sa. J Card Fail. 2012 Aug;18(8):626-34. doi: 10.1016/j.cardfail.2012.05.005. Epub 2012 Jun 19. J Card Fail. 2012. PMID: 22858078 Clinical Trial.
Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
Weiner RB, Baggish AL, Chen-Tournoux A, Marshall JE, Gaggin HK, Bhardwaj A, Mohammed AA, Rehman SU, Barajas L, Barajas J, Gregory SA, Moore SA, Semigran MJ, Januzzi JL Jr. Weiner RB, et al. Among authors: moore sa. Eur J Heart Fail. 2013 Mar;15(3):342-51. doi: 10.1093/eurjhf/hfs180. Epub 2012 Nov 6. Eur J Heart Fail. 2013. PMID: 23132825 Free article. Clinical Trial.
Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.
Gaggin HK, Truong QA, Rehman SU, Mohammed AA, Bhardwaj A, Parks KA, Sullivan DA, Chen-Tournoux A, Moore SA, Richards AM, Troughton RW, Lainchbury JG, Weiner RB, Baggish AL, Semigran MJ, Januzzi JL Jr. Gaggin HK, et al. Among authors: moore sa. Congest Heart Fail. 2013 May-Jun;19(3):135-42. doi: 10.1111/chf.12016. Epub 2012 Dec 28. Congest Heart Fail. 2013. PMID: 23279139 Free article. Clinical Trial.
Serum albumin and mortality in acutely decompensated heart failure.
Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr. Uthamalingam S, et al. Among authors: moore sa. Am Heart J. 2010 Dec;160(6):1149-55. doi: 10.1016/j.ahj.2010.09.004. Am Heart J. 2010. PMID: 21146671
621 results